Beta Drugs (BETA) Share Price rises 8.6% to Rs 1,845.7

Beta Drugs Share Price rose 8.6% to Rs 1,845.7, with market capitalisation at Rs 1,865.81 crore as of 15 October 2026 at 10:45:45 AM IST.

Beta Drugs Share Price is rising today after the stock moved to Rs 1,845.7 from a previous close of Rs 1,699.5. The move leaves the company with a market capitalisation of Rs 1,865.81 crore, which places Beta Drugs Ltd. in the healthcare space as a Pharmaceuticals & Drugs name. Univest figures confirm the price action, but they do not point to a specific company trigger.

The Beta Drugs Share Price update matters because the stock is trading well above its previous close, while the day’s range shows movement between Rs 1,674.2 and Rs 1,870. For readers tracking Beta Drugs Stock News, the verified facts point to a clear same-day share price gain rather than an assumed trigger. In the absence of a stated company-specific reason, the best interpretation is to read the move together with Beta Drugs Fundamental Analysis, valuation ratios and the healthcare sector benchmark. Univest data also shows the stock’s exact market cap, which helps set the company’s scale before looking at its ratios and peer context. Investors watching Beta Drugs Share Price Today can monitor whether the current price holds near the upper end of the day’s range and how the stock compares with listed pharmaceutical peers.

Beta Drugs Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,845.7
Previous Close	Rs 1,699.5
Today's Move	Rs 146.2 (+8.6%)
Open	Rs 1,700
High	Rs 1,870
Low	Rs 1,674.2
Market Capitalisation	Rs 1,865.81 crore
Market Cap Category	Small Cap

Beta Drugs Ltd. (BETA) rose to Rs 1,845.7 from the previous close of Rs 1,699.5, a move of Rs 146.2 or 8.6%. The stock opened at Rs 1,700, reached a high of Rs 1,870, recorded a low of Rs 1,674.2.

Beta Drugs Share Price opened at Rs 1,700, touched a high of Rs 1,870 and a low of Rs 1,674.2, and last traded at Rs 1,845.7. The price rise from the previous close of Rs 1,699.5 to the current price of Rs 1,845.7 is Rs 146.2, or 8.6%.

The move gives Beta Drugs Share Price Today a firmly higher tone in the current market update. The stock is trading near the top of the day’s range, which is a straightforward price action fact rather than a judgment on demand or conviction. In Beta Drugs Stock Performance terms, the gain stands out against the previous close and the opening level, while the market capitalisation remains at Rs 1,865.81 crore. For readers following Beta Drugs Share Price Live, the useful takeaway is simple: the stock is materially above the prior session reference, and the day’s movement has been sustained across a broad intraday band. The next layer of Beta Drugs Stock Analysis comes from fundamentals, where valuation and returns help frame the move.

Beta Drugs Ltd. (BETA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,865.81 crore
P/E Ratio	45.56x
P/B Ratio	7.21x
ROE	23.95%
ROCE	25.23%
EPS	Rs 37.3
Book Value Per Share	Rs 235.8
Dividend Yield	0%

Beta Drugs Ltd. (BETA) fundamental metrics show P/E 45.56x, P/B 7.21x, ROE 23.95%, ROCE 25.23%. Taken on their own, these numbers offer context rather than a trading signal.

Beta Drugs Ltd. has a market capitalisation of Rs 1,865.81 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 45.56x, P/B at 7.21x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 23.95% and ROCE of 25.23%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 37.3, book value per share of Rs 235.8, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.61%, median ROCE of 13.46%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	45.56x
Benchmark Median P/E	31.35x
Benchmark Average P/E	46.92x
Benchmark P/E Range	3.13x to 654.72x
Company P/B Ratio	7.21x
Benchmark Median P/B	2.84x
Company ROE	23.95%
Benchmark Median ROE	11.61%
Company ROCE	25.23%
Benchmark Median ROCE	13.46%
Company Market Capitalisation	Rs 1,865.81 crore
Benchmark Median Market Cap	Rs 827.89 crore

Beta Drugs Ltd. (BETA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Beta Drugs Ltd. (BETA) has a P/E ratio of 45.56x, which is above the benchmark median of 31.35x, a difference of +45.33%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Beta Drugs Ltd. (BETA) has a ROE of 23.95%, which is above the benchmark median of 11.61%, a difference of +106.29%. Beta Drugs Ltd. (BETA) has a ROCE of 25.23%, which is above the benchmark median of 13.46%, a difference of +87.44%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,24,466.35	34.69	4.85	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,46,222.11	81.95	13.57	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,76,300.5	80.12	19.47	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,12,817.68	24.84	4.16	19.69	21.39
Laurus Labs Ltd.	LAURUSLABS	1,10,823.44	100.61	19.51	18.31	18.2

Beta Drugs Ltd. (BETA) has a P/E ratio of 45.56x compared with the displayed peer median of 80.12x. The comparison is relative and should not be read as a recommendation. Its ROE of 23.95% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 25.23% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Beta Drugs Ltd. (BETA) has a market capitalisation of Rs 1,865.81 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Beta Drugs

• Beta Drugs Share Price is up 8.6% today, with the current price at Rs 1,845.7 and the previous close at Rs 1,699.5.
• The day’s range, from Rs 1,674.2 to Rs 1,870, gives a clear price action frame for Beta Drugs Share Price Today.
• ROE of 23.95% and ROCE of 25.23% keep Beta Drugs Fundamental Analysis relevant for market participants.
• P/E of 45.56 and P/B of 7.21 place Beta Drugs Share Price on the richer side versus the same-industry median.
• Beta Drugs Market Cap of Rs 1,865.81 crore sits above the sector median and gives the stock a defined healthcare peer context.

About Beta Drugs Ltd.

Beta Drugs Share Price belongs to Beta Drugs Ltd., a company in the Healthcare sector and the Pharmaceuticals & Drugs industry. The business operates within a segment where company scale, returns and valuation are often read together, so Beta Drugs Stock Analysis is naturally linked to its financial ratios. The company’s market capitalisation of Rs 1,865.81 crore indicates its current market size, while the reported EPS of Rs 37.3 and book value of Rs 235.8 help frame the accounting and earnings base behind Beta Drugs Share Price. Dividend yield is 0%, so the current ratio set does not indicate a cash payout element. For readers following Beta Drugs Company News or Beta Drugs Stock Performance, the key company-level context is that it is a pharmaceuticals and drugs name with return ratios that are above the industry benchmark median. Univest tracks that profile because healthcare stocks often move when price action and valuation stand out together.

Frequently Asked Questions

Why is Beta Drugs Share Price rising today?

Ans. Beta Drugs Share Price is rising today because the stock moved from Rs 1,699.5 to Rs 1,845.7, an 8.6% gain. Univest figures confirm the price action, but they do not point to a specific company trigger.

What is Beta Drugs Share Price today?

Ans. Beta Drugs Share Price today is Rs 1,845.7. The stock is trading above its previous close of Rs 1,699.5, which shows a clear same-day price rise in the latest Univest figures.

What is Beta Drugs market capitalisation?

Ans. Beta Drugs has a market capitalisation of Rs 1,865.81 crore. That places the company above the same-industry median market cap of Rs 827.89 crore, based on the healthcare benchmark set.

How does Beta Drugs Share Price compare with its P/E ratio?

Ans. Beta Drugs Share Price is backed by a P/E ratio of 45.56. That is above the industry median of 31.35 and slightly below the industry average of 46.92 across the benchmark set.

Is Beta Drugs expensive compared with peers?

Ans. Beta Drugs trades at a P/B of 7.21 and a P/E of 45.56. Both are above several listed peers such as Zydus Lifesciences, Cipla and Dr. Reddy’s, so the valuation sits on the richer side.

What do Beta Drugs ROE and ROCE show?

Ans. Beta Drugs reports ROE of 23.95% and ROCE of 25.23%. Both are above the same-industry median and average, which adds useful context to Beta Drugs Fundamental Analysis and the current share price move.

What is Beta Drugs EPS and book value?

Ans. Beta Drugs EPS is Rs 37.3 and book value is Rs 235.8. EPS shows earnings attributable to each share, while book value per share shows the accounting net worth behind each share.

Does Beta Drugs pay a dividend?

Ans. Beta Drugs has a dividend yield of 0. That means the current figure set does not show a dividend income yield, so Beta Drugs Share Price is being assessed mainly on earnings and returns.

Track Beta Drugs Share Price on Univest

Use Beta Drugs Ltd. (BETA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Beta Drugs Share Price can be tracked on Univest alongside live price updates, fundamental ratios, 52-week levels and market insights. For investors reviewing Beta Drugs Share Price Today or Beta Drugs Share Price Live, the platform keeps the key numbers in one place. Univest also helps compare Beta Drugs Stock News with sector and peer context, which is useful when a same-day price rise appears without a stated company-specific catalyst. That makes Beta Drugs Share Price easier to follow through both price action and fundamentals.